Investing Profile

René Kuijten

InvestorVC
Partner, Head of EQT Life Sciences
eqtgroup.com/about/people/ren...Amsterdam, Netherlands
Photo of René Kuijten, Partner at EQT Life Sciences

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$11.0M - $65.0M
$25.0M
6
€260M
CompanyStageDateRound SizeTotal Raised
Artios Pharma
Series DNov 2025$120M
Series CJul 2021$150M
Series BAug 2018$83M
$380M
Co-investors: Barbara Dalton (Pfizer Venture Investments), Jake Simson (RA Capital), Florian Müllershausen (Novartis Venture Fund), Hakan Goker (M Ventures (Merck)), Raphael Wisniewski (Andera Partners)
Neuravi
Series BJun 2015$22M
$22M
Co-investors: Anne Portwich (EQT Life Sciences)
BMEYE
Series BOct 2009$9M
$9M
Co-investors: Thom Rasche (Earlybird Venture Capital)
Syntaxin
Series BOct 2007$32M
$71M
Co-investors: Genghis Lloyd-Harris (Abingworth), Deborah Harland (SR One)